Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 13cyclopia sequence 7Neoplasms 5Polycystic Ovary Syndrome 4Prostatic Neoplasms 3Multiple Myeloma 3Lung Neoplasms 3Leiomyoma 3Head and Neck Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Vomiting 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Obesity 2Neoplasms, Plasma Cell 2Nausea 2Hematologic Diseases 2Fatigue 2Depression 2Weight Loss 1Warts 1Urinary Bladder Neoplasms 1Testicular Neoplasms 1Sleepiness 1Sezary Syndrome 1Prostatic Intraepithelial Neoplasia 1Primary Myelofibrosis 1Peripheral Nervous System Diseases 1Pediatric Crohn's disease 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1

Interventions

Radiotherapy 3Carboplatin 3Trastuzumab 2Magnetic Resonance Spectroscopy 2Cyclophosphamide 2proto-oncogene protein c-fes-fps 1palbociclib 1gallium 68 PSMA-11 1fluciclovine F-18 1Vorinostat 1Thiotepa 1Taxes 1Tamoxifen 1Sugars 1Radiation 1Paclitaxel 1Naltrexone 1Melphalan 1Letrozole 1Fulvestrant 1Fluorine-18 1Drugs, Generic 1Doxorubicin 1Docetaxel 1Crizotinib 1Counseling 1Chemotherapy, Adjuvant 1Albumin-Bound Paclitaxel 168Ga-DKFZ-PSMA-11 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma, Lobular × Sugars × Clear all
NCT02137252 2021-11-16

Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast Cancer

Dana-Farber Cancer Institute

Phase 2 Terminated
3 enrolled 4 charts
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡